“Epigenetic and Proteomic Consequences of PRC2 loss of function

in Malignant Peripheral Nerve Sheath Tumors”

John Wojcik, MD, PhD

Soft Tissue Pathology Fellow, UPHS

snd

"A Patient Safety Curriculum for Pathology Trainees?"

T. Danielle Samulski, MD

Surgical Pathology Fellow, HUP

March 28, 2016

12:00PM-1:00PM

CRB, Austrian Auditorium

Target Audience

This program has been designed for physicians, fellows, residents, researchers in the medical specialties of pathology

Series Educational Objectives

After completing this activity, participants should be able to:

  • Enhance knowledge practice and competence of anatomical pathology diagnosis
  • Enhance knowledge, practice and competence of clinical laboratory testing
  • Enhance knowledge, practice, and competence of transfusion medicine
  • Review new and upcoming therapies to improve clinical management and care of patients
  • Apply knowledge of the pathological basis of disease to improve clinical management and care of patients

Session Educational Objectives

After completing this activity, participants should be able to:

  • Describe the importance of patient safety to the professional mission of pathologists.
  • Explain the challenge of implementing relevant patient safety curricula for AP pathology trainees

Accreditation

Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support* NO

For more information, please contact

Jennifer Wolfe

215-898-2068

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Developmentfor individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME,Zalman Agus, MD,Senior peer reviewerand Patricia A. Smith, MSN, RN-BC,Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.

The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Planning Committee Member Name

Taku Kambayashi, MD, PHD / Kathleen Montone, MD

Presenter Name

John wojcik md, phd

t. danielle samulski, MD

The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.

Planning Committee Member NameName of Commercial InterestRelationship

Warren S. Pear, MD, PHDPfizer, Amgen, Johnson & JohnsonStock/Shareholder

Presenter NameName of Commercial InterestRelationship

Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected

Disclosure of Unapproved Uses of Products

Presenter nameProductInvestigational and/or Off-label Use